- 询价
- 辰辉创聚生物®️
- 中国
- NBAB-136398
- 2026年05月21日
- IHC-P
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
Recombinant Mouse CD3e protein
- 形态：
liquid
- 保存条件：
见COA
- 克隆性：
单克隆
- 保质期：
见COA
- 库存：
大量
- 供应商：
北京辰辉创聚生物技术有限公司
- 应用范围：
IHC-P
- 抗体英文名：
Anti-CD3e Monoclonal Antibody
- 抗体名：
抗鼠CD3e抗体
- 规格：
100ul; 500ul; 1ml
| 产品信息
品名：NebuSelect™ Anti-CD3e Monoclonal Antibody
货号：NBAB-136398
品牌：辰辉创聚生物®️
规格：100ul; 500ul; 1ml
| 产品描述
NebuSelect™ Anti-CD3e Monoclonal Antibody (Cat# NBAB-136398) was produced in Rat immunized with Recombinant Mouse CD3e protein, and it reacts with Mouse. This antibody is validated for IHC-P.
| 产品属性
Product Category：Rat MAb
Reactivity：Mouse, Rat
Specificity：Mouse CD3e
Immunogen：Recombinant Mouse CD3e protein
Isotype：Monoclonal Rat IgG
Purification：Protein A & Protein G Affinity Purification
Buffer：0.2 μm filtered solution in PBS, pH7.4, containing 0.09% Sodium azide, 50% glycerol.
Conjugate：Unconjugated
Applications：IHC-P
Dilution：IHC-P 1:50～1:500
Storage：This liquid antibody can be stored at 2℃-8℃ for at least two weeks. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20℃. When reconstituted in sterile pH 7.4 0.01M PBS or antibody diluent, the antibody is stable for at least two weeks at 2-4℃.
For Research Use Only!
To get more information, please contact us freely.
郑重声明：仅用于科学研究，不可用于诊断或治疗。
更多产品细节，请联系我司相关客服人员。
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Antigen Purification by Monoclonal Antibody Immunoaffinity Chromatography
proteins. Taking advantage of the exquisite specificity afforded by each antibody results in a final purified product that binds specifically to that MAb. Using immunoaffinity chromatography, a single antigen can be separated from very complex mixtures (e.g
Expression and Isolation of Recombinant Antibody Fragments in E. coli
Central to the rapid growth in the study and application of recombinant antibodies in recent years is the ability to reliably and cost-effectively produce large quantities of functional protein. In contrast to glycosylated whole monoclonal
Production of Stabilized scFv Antibody Fragments in the E. coli Bacterial Cytoplasm
Monoclonal antibodies (mAbs) are currently the fastest growing class of therapeutic proteins. Parallel to full-length IgG format the development of recombinant technologies provided the production of smaller recombinant antibody variants
技术资料暂无技术资料 索取技术资料
